AbbVie
ABBV
ABBV
3,710 hedge funds and large institutions have $232B invested in AbbVie in 2024 Q4 according to their latest regulatory filings, with 432 funds opening new positions, 1,493 increasing their positions, 1,399 reducing their positions, and 131 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
0.38% more ownership
Funds ownership: 71.76% → 72.14% (+0.38%)
7% less capital invested
Capital invested by funds: $249B → $232B (-$16.8B)
20% less funds holding in top 10
Funds holding in top 10: 208 → 166 (-42)
Holders
3,710
Holding in Top 10
166
Calls
$3.18B
Puts
$2.99B
Top Buyers
| 1 | +$1.08B | |
| 2 | +$794M | |
| 3 | +$779M | |
| 4 |
Charles Schwab
San Francisco,
California
|
+$640M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$599M |
Top Sellers
| 1 | -$1.47B | |
| 2 | -$1.03B | |
| 3 | -$845M | |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$829M |
| 5 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$736M |